The PennZone

RANCHO SANTA MARGARITA, Calif. - PennZone -- MedWand Solutions, Inc., the ultimate healthcare solution and a pioneer in telehealth technology, is proud to announce its expansion into New Zealand and the South Pacific Islands, with Whānau Tahi appointed as authorized distributor. This latest market expansion will allow Whānau Tahi to empower healthcare providers in the region, elevating primary care standards and increasing patient access to healthcare services.

Whānau Tahi, which translates to "Family First," aligns seamlessly with MedWand's mission to enhance global healthcare accessibility. By providing healthcare professionals with the tools to conduct comprehensive on-site or remote patient examinations, MedWand aims to bridge the gap in healthcare accessibility, particularly in historically underserved areas. The collaboration with Whānau Tahi not only broadens the reach of MedWand's VirtualCare technology but also contributes to the goal of improving patient outcomes in the geographically diverse region.

More on The PennZone

• Maryland Personal Injury Firm Earns National Recognition in 2026 ELA Awards
• Robert J. Bradshaw's AYE is a Gripping Dual Reality Thriller Exploring the Increasingly Blurred Line Between Humanity and Technology
• Bangxing Silicone Revolutionizes Silicone Baby Product Partnerships: Low MOQ Support + VIP Long-Term Win-Win Programs
• JFAB Consulting Elevates Brand with New Identity and Digital Experience
• SteelTree Announces Launch of Its Operational Decision Intelligence Service

"We are thrilled to partner with Whānau Tahi, a company that shares our dedication to transforming healthcare delivery," said Stuart English, MedWand's Senior Director of International Business Development. "Their strong commitment to community well-being and innovative approach to healthcare makes them an ideal partner to introduce MedWand's advanced VirtualCare technologies to New Zealand and the South Pacific Islands."

Whānau Tahi's mission is to transform the model of care and well-being for whānau, their customers, and communities through one journey, one plan, one platform, founded on core values of manaakitanga (hospitality, kindness, generosity, support) and whanaungatanga (a relationship through shared experiences and working together). This mission closely aligns with MedWand's goal of enabling comprehensive and accessible healthcare anywhere in the world.

"Whānau Tahi is excited to partner with MedWand," said Simon Reedy, CEO of Whānau Tahi. "The MedWand partnership represents a major step forward in our mission to improve access to health care for whānau, working with our partners in the whānau ora space."

More on The PennZone

• Advanced AI Capabilities Reflected by Upcoming Company Name and Stock Symbol Change for Evolving Pre-Owned Boat Dealer: Off The Hook YS: N Y S E: OTH
• AI-Driven Defense Expansion, Autonomous Systems and Israeli Aerospace Manufacturing Platform: VisionWave Holdings (N A S D A Q: VWAV)
• AI Predicts the Most Likely 2026 FIFA World Cup Winner
• The AI Production Shift: Why Game Development Is Entering Its Most Accelerated Phase
• World-First AI Humanoid Robot Debuts on Cherie Barber's Ground-breaking Australian Reno Show

Transforming the traditional understanding of telehealth, MedWand combines multiple vitals sensors into one, handheld, lightweight device. Data collected can include core temperature, blood oxygen saturation, pulse rate, heart, lung or abdominal auscultations, electrocardiogram*, and high definition otoscopic, oropharynx, and dermatoscopic exam images. Through approved 3rd party Bluetooth peripherals, MedWand examinations can also seamlessly capture blood pressure, glucometer, spirometry, and weight data. The device's versatility and ease of use make it an asset for both healthcare professionals and patients.

For more information on MedWand visit www.medwand.com. For more information on Whānau Tahi visit www.whanautahi.com. To schedule a private demonstration or to request a formal quotation please contact MedWand at www.medwand.com/contact.html.